This program provides eligible patients with Bayer prescription medicines at no cost. It is designed to assist individuals who face financial challenges and are either uninsured or underinsured, ensuring they can access necessary treatments for cardiovascular, oncology, hematology, and women's healthcare conditions.
Bayer Us Patient Assistance Foundation is a private corporation based in WHIPPANY, NJ. The foundation received its IRS ruling in 2014. The principal officer is % David Adams. It holds total assets of $313M. Annual income is reported at $1.5B. FOR THE YEAR ENDED 12/31/2021, THE FOUNDATION DISTRIBUTED FREE OF CHARGE A VARIETY OF PHARMACEUTICAL PRODUCTS. According to available records, Bayer Us Patient Assistance Foundation has made 2 grants totaling $908M, with a median grant of $454M. Annual giving has grown from $362M in 2020 to $546M in 2022. Individual grants have ranged from $362M to $546M, with an average award of $454M. Grant recipients are concentrated in New Jersey. Contributions to this foundation are tax-deductible.
FOR THE YEAR ENDED 12/31/2020, THE FOUNDATION DISTRIBUTED FREE OF CHARGE A VARIETY OF PHARMACEUTICAL PRODUCTS
Expenses: $362M
PRODUCT DISTRIBUTION COSTS
Expenses: $4.2M
VARIOUS PROFESSIONAL & MISCELLANOUS OPERATING COSTS
Expenses: $4K
FOR THE YEAR ENDED 12/31/2021, THE FOUNDATION DISTRIBUTED FREE OF CHARGE A VARIETY OF PHARMACEUTICAL PRODUCTS. Based on available records, the foundation has funded 2 grants. Its grantmaking reaches organizations primarily in NJ.
Bayer Us Patient Assistance Foundation has distributed a total of $908M across 2 grants. The median grant size is $454M, with an average of $454M. Individual grants have ranged from $362M to $546M.
Assistance limited to persons living in the United States or Puerto Rico, meet certain income limits, and either have no insurance or Bayer prescription is not covered by insurance.
Bayer Us Patient Assistance Foundation is headquartered in WHIPPANY, NJ.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| Brian Nagle | Director | $0 | $0 | $0 |
| Michael J Mcdonald | CHAIR | $0 | $0 | $0 |
| Theresa Natalicchio | Director | $0 | $0 | $0 |
| Karen Dyrness | Vice President | $0 | $0 | $0 |
| Priyal Patel | Treasurer | $0 | $0 | $0 |
Total Giving
$923.9M
Total Assets
$183.5M
Fair Market Value
$183.5M
Net Worth
$183.5M
Grants Paid
$915.2M
Contributions
$972.5M
Net Investment Income
$0
Distribution Amount
$0
Total Grants
2
Total Giving
$908M
Average Grant
$454M
Median Grant
$454M
Unique Recipients
1
Most Common Grant
$362M
of 2022 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Under The Health Insurance Portability And AccountProvide pharmaceutical assistance to qualifying individuals | Whippany, NJ | $546M | 2022 |
NEW BRUNSWICK, NJ
S SAN FRAN, CA
NEW YORK, NY
RIDGEFIELD, CT
PRINCETON, NJ
| Richard K Heller |
| Vice President Tax |
| $0 |
| $0 |
| $0 |
| Richard Liner | Secretary | $0 | $0 | $0 |
| Keith R Abrams | Assistant Secretary | $0 | $0 | $0 |
| Albert Mitchell | President | $0 | $0 | $0 |
| Jeffrey Mcfarland | Tax Officer | $0 | $0 | $0 |
© 2026 Granted AI